Clinical Trial Results

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Strategy for Improving Stroke Treatment Response

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma